Molecular Regulation of Stem Cell Quiescence

干细胞静止的分子调控

基本信息

项目摘要

PROJECT SUMMARY Stem cells are responsible for homeostasis and repair of most of the tissues in the body. Many populations of stem cells persist in a quiescent state until stimulated to enter the cell cycle, proliferate, and differentiate into functional cells of the particular tissue. In recent years, work from our group and others has drawn attention to several unexpected characteristics of quiescent muscle stem cells (MuSCs), many of which are shared by other quiescent stem cell populations. These include the active maintenance of cellular quiescence, unique metabolic and energetic mechanism in quiescent and activating stem cells, and the presence of large numbers of transcripts for which no protein product is detected. This latter observation raises three major questions that are the focus of this proposal: 1) Is the transcriptional profile of MuSCs (or any other stem cell population) in vivo similar to that of cells that have been isolated and purified by fluorescence-activated cell sorting (FACS)? 2) What are the post-transcriptional mechanisms that are responsible for the absence of protein products when transcripts are present in the quiescent cells? 3) What are consequences of accumulation of those protein products in quiescent cells that necessitate mechanisms to prevent such an accumulation? To address these issues, this proposal is divided into three Specific Aims as follows. Aim 1: To study the dynamics of the quiescent and activating MuSC transcriptome. We will use methods to label nascent RNA in vivo (using 4-thiouracil (TU) and 5-ethynyl uridine (EU)) followed by labelled transcript purification and RNA- seq to assess MuSC transcript dynamics in vivo and ex vivo. We will also profile transcripts using RNA-seq of fixed MuSCs to assess transcript abundance in vivo. Aim 2: To study the translatome and proteome of MuSCs in vivo and ex vivo. We will isolate ribosome-associated transcripts (using the RiboTag mouse) followed by RNA-seq and OP-puromycin labelling of labelled proteins followed by mass spectrometry to assess transcripts that are associated with the polyribosome and translated into detectable proteins in quiescent MuSCs in vivo and ex vivo. We will also assess protein translation in MuSCs in vivo and ex vivo during the process of MuSC activation. Aim 3: To understand the regulation of MyoD translation and the consequences of aberrant MyoD protein expression in quiescent MuSCs. Based on Preliminary Data, we will test the hypothesis that Staufen1 suppresses the translation of the MyoD transcript in quiescent cells, and we will analyze the functional consequences of MyoD expression in quiescent MuSCs by inhibiting those suppressive mechanisms genetically and using an siRNA approach. The overall goals of these studies are to provide a more accurate assessment of the in vivo state of the quiescent stem cell and to understand in greater detail the molecular mechanisms that maintain stem cell quiescence and at the same time prime the cell for activation and differentiation.
项目概要 干细胞负责体内大多数组织的稳态和修复。许多人口 的干细胞持续处于静止状态,直到受到刺激进入细胞周期、增殖并分化为 特定组织的功能细胞。近年来,我们小组和其他人的工作引起了人们的关注 静止肌肉干细胞(MuSC)的一些意想不到的特征,其中许多是 其他静止干细胞群。这些包括积极维持细胞静止、独特的 静止和激活干细胞的代谢和能量机制,以及大量存在 未检测到蛋白质产物的转录本。后一个观察提出了三个主要问题: 该提案的重点是:1)MuSC(或任何其他干细胞群)的转录谱是否存在于 体内与通过荧光激活细胞分选(FACS)分离和纯化的细胞相似吗? 2) 转录后机制导致蛋白质产物缺失的原因是什么 转录本存在于静止细胞中吗? 3)这些蛋白质的积累会产生什么后果 静止细胞中的产物是否需要机制来防止这种积累? 为了解决这些问题,该提案分为以下三个具体目标。目标1:研究 静态和激活 MuSC 转录组的动态。我们将使用方法来标记新生RNA 体内(使用 4-硫尿嘧啶 (TU) 和 5-乙炔基尿苷 (EU)),然后进行标记转录物纯化和 RNA- seq 评估 MuSC 体内和离体转录动态。我们还将使用 RNA-seq 分析转录本 固定 MuSC 以评估体内转录本丰度。目标 2:研究 MuSC 的翻译组和蛋白质组 体内和离体。我们将分离核糖体相关转录本(使用 RiboTag 小鼠),然后 对标记蛋白进行 RNA-seq 和 OP-嘌呤霉素标记,然后进行质谱分析以评估转录本 与多核糖体相关并在体内翻译成静态 MuSC 中可检测的蛋白质 和离体。我们还将在 MuSC 过程中体内和离体评估 MuSC 中的蛋白质翻译 激活。目标 3:了解 MyoD 翻译的调控以及异常 MyoD 的后果 静态 MuSC 中的蛋白质表达。根据初步数据,我们将检验以下假设:Staufen1 抑制静止细胞中 MyoD 转录物的翻译,我们将分析其功能 通过抑制这些抑制机制,静态 MuSC 中 MyoD 表达的后果 遗传并使用 siRNA 方法。这些研究的总体目标是提供更准确的 评估静止干细胞的体内状态并更详细地了解分子 维持干细胞静止并同时为细胞激活做好准备的机制 差异化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS A. RANDO其他文献

THOMAS A. RANDO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS A. RANDO', 18)}}的其他基金

Genomic Instability as A Driver of Stem Cell Exhaustion
基因组不稳定性是干细胞衰竭的驱动因素
  • 批准号:
    10722284
  • 财政年份:
    2023
  • 资助金额:
    $ 4万
  • 项目类别:
Molecular Regulation of Stem Cell Quiescence
干细胞静止的分子调控
  • 批准号:
    10685860
  • 财政年份:
    2022
  • 资助金额:
    $ 4万
  • 项目类别:
Epigenetic Reprogramming of Cellular Age
细胞年龄的表观遗传重编程
  • 批准号:
    10195469
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Mechanisms of adipogenic and fibrotic degeneration of muscle
肌肉脂肪形成和纤维变性的机制
  • 批准号:
    10259577
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Epigenetic Reprogramming of Cellular Age
细胞年龄的表观遗传重编程
  • 批准号:
    10616595
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Aging and Stem Cell Resilience
衰老和干细胞恢复能力
  • 批准号:
    10380730
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Epigenetic Reprogramming of Cellular Age
细胞年龄的表观遗传重编程
  • 批准号:
    10516941
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Aging and Stem Cell Resilience
衰老和干细胞恢复能力
  • 批准号:
    10544774
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Aging and Stem Cell Resilience
衰老和干细胞恢复能力
  • 批准号:
    10209216
  • 财政年份:
    2021
  • 资助金额:
    $ 4万
  • 项目类别:
Molecular Regulation of Stem Cell Quiescence
干细胞静止的分子调控
  • 批准号:
    10174500
  • 财政年份:
    2020
  • 资助金额:
    $ 4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了